Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Biomerica (BMRA) over the last 15 years, with Q4 2025 value amounting to $32000.0.

  • Biomerica's Asset Writedowns and Impairment rose 90000.0% to $32000.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $70000.0, marking a year-over-year increase of 130000.0%. This contributed to the annual value of $8000.0 for FY2025, which is 18000.0% up from last year.
  • Latest data reveals that Biomerica reported Asset Writedowns and Impairment of $32000.0 as of Q4 2025, which was up 90000.0% from $38000.0 recorded in Q3 2025.
  • In the past 5 years, Biomerica's Asset Writedowns and Impairment ranged from a high of $649419.0 in Q1 2021 and a low of -$714747.0 during Q4 2021
  • For the 5-year period, Biomerica's Asset Writedowns and Impairment averaged around $31689.7, with its median value being $6500.0 (2024).
  • As far as peak fluctuations go, Biomerica's Asset Writedowns and Impairment surged by 339817.54% in 2021, and later tumbled by 664772.85% in 2023.
  • Biomerica's Asset Writedowns and Impairment (Quarter) stood at -$714747.0 in 2021, then surged by 119.45% to $139000.0 in 2022, then soared by 243.88% to $478000.0 in 2023, then plummeted by 100.84% to -$4000.0 in 2024, then skyrocketed by 900.0% to $32000.0 in 2025.
  • Its Asset Writedowns and Impairment stands at $32000.0 for Q4 2025, versus $38000.0 for Q3 2025 and $1000.0 for Q2 2025.